Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of ...

After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on ...

Cambridge, USA-based biotech Sage Therapeutics yesterday announced that, while rejecting an unsolicited takeover offer, its ...

Robert Kennedy Jr. indicated he would consider authorizing the government to seize patents of high-priced medicines to lower ...

Anti-abortion groups aren’t lobbying against RFK Jr., U.S. reported first case of H5N9 bird flu strain, Sage Therapeutics ...

Sage Therapeutics has a unique approach to targeting ... there’s a trend of recent CNS drugs being acquired by other big pharma companies in the sector. It could also be simply that BIIB saw ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

Sage Therapeutics has left its view of ... like its 2023 purchase of Reata Pharma and its rare disease therapy Skyclarys (omaveloxolone) for $7.3 billion and last year's $1.1 billion takeover ...

Moderna provides updates on its business and pipeline progress at the J.P. Morgan Healthcare Conference. Moderna reported preliminary product sales between $3 billion and $3.1 billion for 2024 ...